Company Name or Ticker Symbol
Search for other Categories
Orgenesis Inc.  (ORGS)
Other Ticker:  
    Sector  Healthcare    Industry Biotechnology & Drugs


Company Fail to Break-even Despite Surge in Sales

decrease font size NEWS BETA Increase font size

Orgenesis Inc announced first quarter 2017 operating loss of $-3.446 millions

Orgenesis Inc announced very strong Sales growth year on year to $2 millions in the first quarter 2017, but increased losses at $-0.08.

Compare to previous quarter eps fell from $0.11 per share and by -71.03 % from $6 millions.

For the first quarter 2017 Orgenesis Inc logged net loss of $-9 million, instead of break-even in the same quarter a year before.
Other ORGS's Earnings Reports

Orgenesis reported forth quarter 2016 earnings

Orgenesis reported third quarter 2016 earnings

Orgenesis reported second quarter 2016 earnings

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com